Rigby, M. R., Harris, K. M., Pinckney, A., DiMeglio, L. A., Rendell, M. S., Felner, E. I., . . . Ehlers, M. R. (2015). Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients. J Clin Invest.
Chicago-стиль цитированияRigby, Mark R., et al. "Alefacept Provides Sustained Clinical and Immunological Effects in New-onset Type 1 Diabetes Patients." J Clin Invest 2015.
MLA-цитированиеRigby, Mark R., et al. "Alefacept Provides Sustained Clinical and Immunological Effects in New-onset Type 1 Diabetes Patients." J Clin Invest 2015.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.